{"id":267,"date":"2019-01-18T16:00:53","date_gmt":"2019-01-18T15:00:53","guid":{"rendered":"http:\/\/mapkinhibitorlibrary.com\/?p=267"},"modified":"2022-01-17T11:37:55","modified_gmt":"2022-01-17T02:37:55","slug":"pathogenesis-ra-supported-presence-autoantibodies","status":"publish","type":"post","link":"http:\/\/mapkinhibitorlibrary.com\/index.php\/2019\/01\/18\/pathogenesis-ra-supported-presence-autoantibodies\/","title":{"rendered":"In the pathogenesis of RA is supported by the presence of autoantibodies"},"content":{"rendered":"<p>To facilitate functional genomics in the nervous system, an appropriate methodology should be taken for conditional genetic manipulation to the purpose. Our system has the potential to be a tool with which to elucidate the in vivo molecular mechanisms of later stages of development. Rheumatoid arthritis is a chronic autoimmune disease that features persistent synovial inflammation and proliferation along with infiltration of predominantly T lymphocytes, plasma cells and macrophages. A central role for the B lymphocytes in the pathogenesis of RA is supported by the presence of <a href=\"http:\/\/www.abmole.com\/products\/4-chloropropiophenone.html\">4&#8242;-Chloropropiophenone<\/a> autoantibodies, which are locally produced in the inflamed synovium and may promote tissue inflammation and destruction by forming immune complexes. Moreover, a significant percentage of RA patients display ectopic lymphoid structures in the synovial membrane that could sustain T and B cell interaction. Finally, effector B cells produce cytokines and other immunological mediators thereby promoting the extent and direction of immune responses. The observation that therapeutic B cell depletions using rituximab treatment disrupts synovial lymphoid neogenesis and decreases macrophages infiltration supports the notion that B cells orchestrate synovial inflammation in RA. In the rheumatoid joint, the synovial fluid contains a variety of cytokines, chemokines, growth factors and lipid-derived mediators, which potentially mediate B cells effector functions. Of the prostaglandins, high levels are reached by prostaglandin E2, which plays a prominent role in the rheumatoid <a href=\"http:\/\/www.abmole.com\/products\/eupalinilide-d.html\">Eupalinilide-D<\/a> pathogenic process by promoting tissue damaging and autoimmunity. Microsomal prostaglandin E2 synthase 1 catalyses its formation from cyclooxygenase-derived PGH2 and is an inflammation-induced enzyme overexpressed in synovial tissue of RA patients. MPGES1 is mostly found in fibroblast-like synoviocytes and macrophages. Cyclooxygenase enzymes known as COX-1 and COX-2 are also widely expressed in the inflamed synovium. COX-1 is present in intimal lining layer and synovial sublining mononuclear cells and FLS. COX2 has a similar localization, but is also highly expressed by endothelial cells. Furthermore, whereas COX-1 expression is independent of the inflammatory status in the joint tissue, COX-2 is markedly upregulated at sites of inflammation.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>To facilitate functional genomics in the nervous system, an appropriate methodology should be taken for conditional genetic manipulation to the purpose. Our system has the potential to be a tool with which to elucidate the in vivo molecular mechanisms of later stages of development. Rheumatoid arthritis is a chronic autoimmune disease that features persistent synovial &hellip; <a href=\"http:\/\/mapkinhibitorlibrary.com\/index.php\/2019\/01\/18\/pathogenesis-ra-supported-presence-autoantibodies\/\" class=\"more-link\">Continue reading <span class=\"screen-reader-text\">In the pathogenesis of RA is supported by the presence of autoantibodies<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[1],"tags":[],"_links":{"self":[{"href":"http:\/\/mapkinhibitorlibrary.com\/index.php\/wp-json\/wp\/v2\/posts\/267"}],"collection":[{"href":"http:\/\/mapkinhibitorlibrary.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/mapkinhibitorlibrary.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/mapkinhibitorlibrary.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/mapkinhibitorlibrary.com\/index.php\/wp-json\/wp\/v2\/comments?post=267"}],"version-history":[{"count":1,"href":"http:\/\/mapkinhibitorlibrary.com\/index.php\/wp-json\/wp\/v2\/posts\/267\/revisions"}],"predecessor-version":[{"id":268,"href":"http:\/\/mapkinhibitorlibrary.com\/index.php\/wp-json\/wp\/v2\/posts\/267\/revisions\/268"}],"wp:attachment":[{"href":"http:\/\/mapkinhibitorlibrary.com\/index.php\/wp-json\/wp\/v2\/media?parent=267"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/mapkinhibitorlibrary.com\/index.php\/wp-json\/wp\/v2\/categories?post=267"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/mapkinhibitorlibrary.com\/index.php\/wp-json\/wp\/v2\/tags?post=267"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}